Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,125	1,286	1,291	614	2,966	1,750
Market Cap Growth	-0.41%	-0.41%	110.30%	-79.30%	69.42%	-20.79%
Enterprise Value	833	1,025	1,047	246	2,688	1,367
Last Close Price	8.10	8.98	8.99	4.32	22.87	13.83
PE Ratio	202.50	223.53	-	-	-	-
Forward PE	17.42	24.06	-	-	-	-
PS Ratio	4.93	5.47	7.36	4.58	65.03	34.93
PB Ratio	3.02	3.41	3.42	1.51	6.19	4.29
P/TBV Ratio	2.98	3.45	3.46	1.54	6.30	4.39
P/FCF Ratio	25.22	29.15	-	-	-	-
P/OCF Ratio	25.06	28.97	-	-	-	-
EV/Sales Ratio	3.54	4.36	5.97	1.84	58.94	27.27
EV/EBITDA Ratio	26.07	32.08	-	-	-	-
EV/EBIT Ratio	66.57	81.91	-	-	-	-
EV/FCF Ratio	18.89	23.25	-	-	-	-
Debt / Equity Ratio	0.21	0.21	0.26	0.02	0.02	0.02
Debt / EBITDA Ratio	2.42	2.42	-	-	-	-
Debt / FCF Ratio	1.80	1.80	-	-	-	-
Asset Turnover	0.43	0.43	0.35	0.26	0.09	0.13
Inventory Turnover	1.24	1.24	1.98	2.30	3.14	-
Quick Ratio	4.05	4.05	4.86	8.76	11.84	12.45
Current Ratio	4.57	4.57	5.50	9.60	12.63	13.11
Return on Equity (ROE)	1.52%	1.52%	-19.92%	-24.46%	-40.81%	-29.07%
Return on Assets (ROA)	1.42%	1.42%	-10.53%	-13.74%	-22.43%	-16.54%
Return on Capital (ROIC)	1.68%	1.68%	-12.06%	-15.46%	-24.99%	-18.24%
Return on Capital Employed (ROCE)	2.80%	2.80%	-	-	-	-
Earnings Yield	0.52%	0.45%	-6.04%	-17.62%	-6.10%	-5.87%
FCF Yield	3.96%	3.43%	-2.65%	-13.00%	-5.33%	-4.32%
Buyback Yield / Dilution	-2.07%	-2.07%	-0.93%	-9.70%	-9.20%	-27.36%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q